A combination comprising two or more mRNA molecules, or a single mRNA molecule encoding a first molecule, which is a therapeutic or immunogenic protein or peptide, and a second molecule, which is a protein or a peptide having the ability to modulate an immune response against the first molecule and/or the translation product of the first molecule, wherein the combination comprises:
- (i) at least one first mRNA molecule encoding a first molecule, which is a therapeutic or immunogenic protein or peptide, and
- (ii) at least one second mRNA molecule encoding a second molecule, which is a protein or a peptide having the ability to modulate an immune response against the first molecule and/or the translation product of the first molecule,
- wherein the at least one first mRNA molecule and the at least one second mRNA molecule are co-formulated into a single vector, or wherein the at least one first mRNA molecule and the at least one second mRNA molecule are formulated into two separate compositions, optionally wherein the two separate compositions are mixed prior to administration to form a combined composition, or wherein the first molecule and the second molecule are translated from the single mRNA molecule,
- wherein the at least one second mRNA molecule or a part of the single mRNA molecule encoding the second molecule is selected from the group consisting of an mRNA molecule encoding a cell-bound, or membrane-anchored, agonistic antibody or agonistic antibody fragment, or an agonistic peptide against a cell-bound, or membrane-anchored, receptor or ligand, an mRNA molecule encoding for a cell-bound, or membrane-anchored, receptor or ligand, an mRNA molecule encoding a chemokine or a cytokine, an mRNA molecule encoding an antagonistic antibody or an antagonistic antibody fragment against an immune checkpoint protein, an mRNA molecule encoding an immune checkpoint inhibitor, an mRNA molecule encoding an immune checkpoint, and an mRNA molecule encoding a transcription factor.